Arthneeti
GS

Galaxy Surfactants Ltd

Q4 FY26Chemicals & Petrochemicals

Galaxy Surfactants Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management guided on revenue, margins and order book.

Price₹2,333
Market cap₹7.1K Cr
P/E25.6
Updated23 Aug 2026
Read4 min read

The short version

Q1 FY '27 volume growth guidance: 6% to 8%, targeting higher end of the range (Page 15). Q1 FY '27 volume growth guidance: 6% to 8%; EBITDA per metric ton expected at upper band (~INR 21,000).

From Galaxy Surfactants Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Q1 FY '27 volume growth guidance: 6% to 8%, targeting higher end of the range (Page 15).
  • EBITDA per metric ton expected to improve to INR 21,000 (Page 15).
  • Specialty Ingredients focus likely to drive medium to long-term growth with capacities commissioned in last 1.5 years expected to contribute from FY '27 onwards (Page 13).
  • India market volume growth outlook: 8%-10% possible, subject to monsoon and energy prices impacting demand (Page 14).
  • AMET market volumes (~3%-4%) have bottomed out and expected to improve from coming quarters (Page 17).
  • Potential volume restocking in AMET post geopolitical resolution could spur growth (Page 12).

2 more points from Galaxy Surfactants Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what Galaxy Surfactants Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • The company incurred around INR 480 crores of capex over the last 3 years, mainly focused on the Specialty Ingredients segment.
  • Maintenance capex is typically INR 20-30 crores per year.
  • Growth capex in recent years has been largely on specialty ingredients.
  • For FY '27, no major new growth capex commitments are planned; only routine or brownfield and replacement capex expected.
  • Some work-in-progress capex will get capitalized in FY '27, but no new large projects are planned.
  • The company is well-prepared to leverage existing capacities to capitalize on supply-side opportunities.

2 more points from Galaxy Surfactants Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Shiv Texchem Ltd
Rev 1Mar 2
2Kiri Industries Ltd
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Galaxy Surfactants Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript provided from Galaxy Surfactants Limited's Q4 FY 2025-26 earnings call does not explicitly mention current or expected order book or pending orders details. However, key related points from the management commentary include: - There was some backlog and delayed dispatches in Q4, especially in Latin America and Europe, due to freight rate hikes and logistical challenges, which are being cleared in Q1. - The company is seeing signs of improved demand and ramp-up in their Specialty Ingredients pipeline. - Management indicated that if energy prices and macroeconomic conditions remain stable, volume growth of 6% to 8% and EBITDA at the higher end of guidance are expected for Q1.

2 more points from Galaxy Surfactants Ltd's call on order book

Pro opens every point from 15K+ earnings calls

Galaxy Surfactants Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹1.3K Cr, net profit ₹62 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Continue your research

What Galaxy Surfactants Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • Vishnu Chemicals Ltd (Q4 FY26)

    Q4 FY26 Operating Revenues: ₹450.3 crore, up 14.7% YoY from ₹392.6 crore in Q4 FY25 (Page 5). Key investor presentation takeaways from Vishnu Chemicals Ltd's Q4

  • Neochem Bio Solutions Ltd (Q4 FY26)

    Capacity utilization improved from ~35% in FY24 to 53% in FY26, with significant headroom (47%) for growth without major capex. Key concall takeaways from…

  • SPEB Adhesives Ltd (Q4 FY26)

    The company plans to double its manufacturing capacity, currently at about 80% utilization, with new capacity ramp-up phased over time. Key concall takeaways…

  • Chemfab Alka. (Q4 FY26)

    Chlor Alkali segment: ₹55.63 crore (down 1.21% YoY from ₹56.31 crore) . Key concall takeaways from Chemfab Alkalis Ltd's Q4 FY26 earnings call — and how it…

Compare:vs Solar Industriesvs SRF Ltdvs Linde India Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Galaxy Surfactants Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Galaxy Surfactants Ltd Q4 FY26 results?

Q1 FY '27 volume growth guidance: 6% to 8%, targeting higher end of the range (Page 15). Q1 FY '27 volume growth guidance: 6% to 8%; EBITDA per metric ton expected at upper band (~INR 21,000).

What is Galaxy Surfactants Ltd share price analysis?

Galaxy Surfactants Ltd currently shows a neutral. The stock trades at a P/E of 25.6 with a market cap of ₹7,112 Cr. Investors should review the full earnings analysis for detailed insights.

Is Galaxy Surfactants Ltd planning capital expenditure?

The company incurred around INR 480 crores of capex over the last 3 years, mainly focused on the Specialty Ingredients segment.

Keep Galaxy Surfactants Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.